Understanding and preventing osteoarthritis and its effects
Official title: Administrative Core
Funded at Boston University Medical Campus · NIH-11056739 · Data updated 2026-11-12
This study is looking into what causes osteoarthritis and how we can prevent it, so people living with this condition can have less pain and better movement in their daily lives.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston University Medical Campus NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | June 1, 2023 |
| Project end | February 29, 2028 |
| Funding year | 2025 |
| Award (this year) | $1,157,874 |
| NIH project number | 5U19AG076471-03 |
| Project ID | NIH-11056739 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk for or currently experiencing osteoarthritis and its related symptoms.
✕Less likely to help
Patients with conditions unrelated to osteoarthritis or those who do not have risk factors for OA may not benefit from this research.
What this research studies
This research focuses on the Multicenter Osteoarthritis Study (MOST), which aims to investigate the causes and prevention of osteoarthritis (OA) and its impact on pain and functional ability. The project will involve collecting, managing, and analyzing data related to OA, including risk factors and the consequences of the disease. Patients may benefit from improved understanding and potential prevention strategies for OA through the findings of this research.
Why it matters
Potential benefit: If successful, this research could lead to better prevention strategies and management of osteoarthritis, improving quality of life for patients.
How similar studies have gone: Previous cycles of the MOST study have shown success in advancing knowledge about osteoarthritis, indicating that this approach is built on a foundation of established research.
Where this research is happening
-
Boston University Medical Campus
Boston, United States Active
Researchers
- Principal investigator: Felson, David Tobin — Boston University Medical Campus
- Study coordinator: Felson, David Tobin
Related research
Other NIH-funded projects on the same topics.
-
Creating a detailed map of early lung cancer changes
This study is looking at early changes in lung tissue that can lead to cancer, specifically focusing on common types of lung cancer, and it's for patients who want to help researchers understand these changes better so they can improve early detection and treatment.
-
Telomere trouble in ALT cancers: what causes damage and how it happens
Researchers are studying why some cancer cells use ALT to lengthen telomeres and how replication stress damages telomeres, aiming to uncover key processes that could be targeted in patients.
-
IL-6 signaling, lung injury, and post-TB lung disease in TB/HIV
This grant tests how a specific immune signal (IL-6) relates to lung damage after tuberculosis in people with and without HIV, aiming to understand who is at risk for lasting lung problems.
-
IL-6 signaling and lung injury after TB and HIV co-infection
This project looks at how a common immune signal called IL-6 relates to lung injury after TB treatment, especially in people who also have HIV.
-
LEAD Africa: advancing Alzheimer’s research across Africa
A new project aims to build Alzheimer’s disease research capabilities in Africa to improve understanding and care for people with dementia.
-
Leading AD and related dementias research in Africa
A multi-country effort aims to build Africa’s capacity to study Alzheimer’s disease and related dementias using scalable, low-cost methods.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.